Fenoglide

Fenoglide is a brand name of fenofibrate, approved by the FDA in the following formulation(s):

FENOGLIDE (fenofibrate - tablet; oral)

• 
  Manufacturer: SANTARUS
  
  Approval date: August 10, 2007
  
  Strength(s): 120MG ^[RLD], 40MG
  

Has a generic version of Fenoglide been approved?

No. There is currently no therapeutically equivalent version of Fenoglide available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Fenoglide. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Solid dosage form comprising a fibrate
  Patent 7,658,944
  Issued: February 9, 2010
  Inventor(s): Holm; Per & Norling; Tomas
  Assignee(s): LifeCycle Pharma A/S
  The invention provides stable, solid dosage forms and pharmaceutical compositions in particulate form comprising a fibrate, for example fenofibrate, dissolved in an non-aqueous vehicle in order to ensure improved bioavailability of the active ingredient upon oral administration relative to known fibrate formulations.
  
  Patent expiration dates:
  
  
  • December 9, 2024
    
    ✓ 
    Drug product
  
  

See also...

• Fenoglide Consumer Information (Cerner Multum)
• Fenoglide Advanced Consumer Information (Micromedex)
• Fenofibrate Consumer Information (Drugs.com)
• CIP - Fenofibrate Consumer Information (Wolters Kluwer)
• Fenofibrate Consumer Information (Wolters Kluwer)
• Fenofibrate Consumer Information (Cerner Multum)
• Fenofibrate Advanced Consumer Information (Micromedex)
• Fenofibrate AHFS DI Monographs (ASHP)